JPH07502975A - 抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物 - Google Patents
抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物Info
- Publication number
- JPH07502975A JPH07502975A JP4505220A JP50522092A JPH07502975A JP H07502975 A JPH07502975 A JP H07502975A JP 4505220 A JP4505220 A JP 4505220A JP 50522092 A JP50522092 A JP 50522092A JP H07502975 A JPH07502975 A JP H07502975A
- Authority
- JP
- Japan
- Prior art keywords
- nitroso
- cells
- compounds
- benzopyrone
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
- 1.下記式: (I)▲数式、化学式、表等があります▼〔式中、R1,R2,R3,R4,R 5、及びR6は、水素及びニトロソから成る群から選択され、そしてR1,R2 ,R3,R4,R5、及びR6のうちたった1つはニトロソ基である〕を有する 化合物。
- 2.前記R4がニトロソ基である請求の範囲第1項記載の化合物。
- 3.下記式: ▲数式、化学式、表等があります▼ を有する化合物。
- 4.下記式: (III)▲数式、化学式、表等があります▼〔式中、R1,R2,R3,R4 、及びR5は、水素及びニトロソから成る群から選択され、そしてR1,R2, R3,R4、及びR5のうちたった1つはニトロソ基である〕を有する化合物。
- 5.R2又はR4がニトロソ基である請求の範囲第4項記載の化合物。
- 6.癌及びレトロウイルス疾患の処理のための組成物であって、請求の範囲第1 項記載の化合物を含んで成る組成物。
- 7.癌及びレトロウイルス疾患の処理のための組成物であって、下記式: ▲数式、化学式、表等があります▼ 〔式中、R1,R2、及びR3は水素及びニトロソから成る群から選択され、そ してR1,R2、及びR3のうちたった1つはニトロソ基である〕で表わされる 化合物を含んで成る組成物。
- 8.癌及びレトロウイルス疾患の処理のための組成物であって、請求の範囲第4 項記載の化合物を含んで成る組成物。
- 9.癌及びレトロウイルス疾患の処理のための方法であって、請求の範囲第1項 記載の化合物の有効量を投与する段階を含んで成る方法。
- 10.癌及びレトロウイルス疾患の処理のための方法であって、下記式: ▲数式、化学式、表等があります▼ 〔式中、R1,R2、及びR3は水素及びニトロソから成る群から選択され、そ してR1、R2、及びR3のうちたった1つはニトロソ基である〕で表わされる 請求の範囲第2項記載の化合物の有効量を投与する段階を含んで成る方法。
- 11.癌及びレトロウイルス疾患の処理のための方法であって、請求の範囲第4 項記載の化合物の有効量を投与する段階を含んで成る方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78080991A | 1991-10-22 | 1991-10-22 | |
US780,809 | 1991-10-22 | ||
PCT/US1991/008902 WO1993007868A1 (en) | 1991-10-22 | 1991-11-26 | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-tumor and anti-retroviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07502975A true JPH07502975A (ja) | 1995-03-30 |
JP3070767B2 JP3070767B2 (ja) | 2000-07-31 |
Family
ID=25120767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4505220A Expired - Lifetime JP3070767B2 (ja) | 1991-10-22 | 1991-11-26 | 抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0609211A4 (ja) |
JP (1) | JP3070767B2 (ja) |
AU (1) | AU676992B2 (ja) |
CA (1) | CA2121900A1 (ja) |
WO (1) | WO1993007868A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5652260A (en) * | 1991-10-22 | 1997-07-29 | Octamer, Inc. | Adenosine diphosphoribose polymerase binding nitroso aromatic compound useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents |
US5464871A (en) | 1993-05-12 | 1995-11-07 | Octamer, Inc. | Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
US5877185A (en) * | 1991-10-22 | 1999-03-02 | Octamer, Inc. | Synergistic compositions useful as anti-tumor agents |
AU5298693A (en) * | 1992-11-02 | 1994-05-24 | Emory University | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents |
GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
IL129871A (en) | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
CA2612979A1 (en) * | 2005-06-10 | 2006-12-21 | Bipar Sciences, Inc. | Parp modulators and treatment of cancer |
AU2007292302A1 (en) * | 2006-09-05 | 2008-03-13 | Bipar Sciences, Inc. | Methods for designing PARP inhibitors and uses thereof |
US11433074B2 (en) | 2017-06-22 | 2022-09-06 | Triact Therapeutics, Inc. | Methods of treating glioblastoma |
US11628144B2 (en) | 2017-09-29 | 2023-04-18 | Triact Therapeutics, Inc. | Iniparib formulations and uses thereof |
-
1991
- 1991-11-26 EP EP92904892A patent/EP0609211A4/en not_active Ceased
- 1991-11-26 CA CA002121900A patent/CA2121900A1/en not_active Abandoned
- 1991-11-26 AU AU12609/92A patent/AU676992B2/en not_active Ceased
- 1991-11-26 JP JP4505220A patent/JP3070767B2/ja not_active Expired - Lifetime
- 1991-11-26 WO PCT/US1991/008902 patent/WO1993007868A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP3070767B2 (ja) | 2000-07-31 |
AU1260992A (en) | 1993-05-21 |
EP0609211A1 (en) | 1994-08-10 |
WO1993007868A1 (en) | 1993-04-29 |
AU676992B2 (en) | 1997-04-10 |
EP0609211A4 (en) | 1995-02-01 |
CA2121900A1 (en) | 1993-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5262564A (en) | Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents | |
US5516941A (en) | Specific inactivators of "retroviral" (asymmetric) zinc fingers | |
US5482975A (en) | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents | |
US5473074A (en) | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54 | |
US5753674A (en) | Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents, anti-retroviral agents and anti-tumor agents | |
Li et al. | Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue | |
EP1962843B1 (en) | Use of parp-1 inhibitors | |
US5464871A (en) | Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents | |
JP3042711B2 (ja) | 細胞静止及び抗ウィルス剤として有用な新規5−ヨード−6−アミノ−1,2−ベンゾピロン及びそれらの類似体 | |
JPH07502975A (ja) | 抗腫瘍及び抗―レトロウィルス剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物 | |
CN103502219A (zh) | 作为治疗剂的新型小分子 | |
JPH07233065A (ja) | ピリリウム塩又はピリリウム類似塩を含む光化学治療薬 | |
US9399644B2 (en) | [1,3] dioxolo [4,5-G] quinoline-6(5H)thione derivatives as inhibitors of the late SV40 factor (LSF) for use in treating cancer | |
JPH07500581A (ja) | 6−〔X−(2−ヒドロキシエチル)アミノアルキル〕−5,11−ジオキソ−5,6−ジヒドロ−11H−インデノ〔1,2−c〕イソキノリン誘導体、それらの製造方法およびそれらの使用 | |
US5238947A (en) | Synthetic piperidinediones with cytostatic activity | |
EP1313459B1 (en) | Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents | |
JP2767176B2 (ja) | 抗癌剤 | |
JPH10504517A (ja) | 抗レトロウイルス剤および抗腫瘍剤として有用なアデノシンジホスホリボースポリメラーゼ結合性ニトロソ芳香族化合物 | |
WO2010103067A1 (en) | Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer | |
JP4768909B2 (ja) | トポイソメラーゼ阻害剤 | |
WO1991016309A1 (en) | Synthetic piperidinediones with cytostatic activity | |
JPS61129124A (ja) | 抗腫瘍剤 | |
CN117229147A (zh) | 一类3,4-二羟基苯甲酸酯化合物及其制备方法与用途 | |
JPH04506796A (ja) | ウィルス感染及び腫瘍の処理のためのD―アスパラギン酸β―ヒドロキサメート | |
KR20020001244A (ko) | 새로운 나프토퀴논 화합물 및 이를 함유하는 항암제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090526 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090526 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100526 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110526 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110526 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120526 Year of fee payment: 12 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120526 Year of fee payment: 12 |